Experimental Cancer Drug Sees 100% Success Rate In Clinical Trial
by from on (#60B9P)
A small clinical trial testing the experimental drug dostarlimab saw 100% of rectal cancer cases go into remission, with oncologists saying the unprecedented results have the potential of being a huge step forward in cancer research. What do you think?